Preliminary results of TATTON, a multi-arm phase Ib trial of AZD9291 combined with MEDI4736, AZD6094 or selumetinib in EGFR-mutant lung cancer.
Resource
J. Clin. Oncol., 33(15),
Journal
J. Clin. Oncol.
Journal Volume
33
Journal Issue
15
Pages
-
Date Issued
2015
Date
2015
Author(s)
Oxnard, Geoffrey R.
Ramalingam, Suresh S.
Ahn, Myung-Ju
Kim, Sang-We
Yu, Helena Alexandra
Saka, Hideo
Horn, Leora
Goto, Koichi
Ohe, Yuichiro
Cantarini, Mireille
Frewer, Paul
Lahn, Michael
Yang, James Chih-Hsin
SDGs